A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Filamon LTD
University Hospital Heidelberg
Hoosier Cancer Research Network
UMC Utrecht
Shanghai Chest Hospital
Essen Biotech
Memorial Sloan Kettering Cancer Center
Novartis
Tango Therapeutics, Inc.
University of Nebraska
Adela, Inc
NRG Oncology
NRG Oncology
Dysplasia Diagnostics Limited
Var2 Pharmaceuticals
Mayo Clinic
University of Washington
City of Hope Medical Center
Sun Yat-sen University
Dana-Farber Cancer Institute
Mayo Clinic
Latin American Cooperative Oncology Group
LigaChem Biosciences, Inc.
Institut Cancerologie de l'Ouest
Jonsson Comprehensive Cancer Center
Apollomics Inc.
Columbia University
Institut du Cancer de Montpellier - Val d'Aurelle
Stanford University
Dana-Farber Cancer Institute
Second Affiliated Hospital of Guangzhou Medical University
Xiangya Hospital of Central South University
Assistance Publique - Hôpitaux de Paris
Avera McKennan Hospital & University Health Center
Kaohsiung Medical University Chung-Ho Memorial Hospital
Hospices Civils de Lyon